One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type of blood cancer called acute myeloid leukemia (AML) is notorious for this. Now, new research from The…
RUNX1C isoform identified as driver of chemoresistance in acute myeloid leukemia
